Wendy's rejects $1.4 billion take-private bid from Trian-led group, adopts poison pill

Wendy's independent board committee on November 5 unanimously rejected an unsolicited, non-binding proposal from an investor group led by Trian Fund Management to take the burger chain private at $7.35 per share in cash, a deal valued at about $1.4 billion. The board also adopted a limited-duration shareholder rights plan, commonly called a poison pill.

The committee, which is unaffiliated with Trian and its partners, said the proposal "substantially undervalues the Company" and does not reflect the value it expects the restaurant system to create through Dave's Way, the turnaround plan Wendy's laid out alongside its third-quarter results.

A franchisee on the buy side

The investor group comprised Trian Partners, Flynn Group LP, BlueFive Capital and Sixth Street Partners. Flynn Group is one of Wendy's largest franchisees, according to Food Business News, which put one of the system's own restaurant operators on the buy side of the proposal.

The offer, disclosed in an October 27 filing with the Securities and Exchange Commission, represented a 20% premium to Wendy's closing price of $6.14 that day. The stock rose as high as $7.20 on October 28 before closing at $7.03, Food Business News reported.

In that filing, as quoted by Food Business News, Trian said "private ownership is the better path" and that the business requires significant capital investment to de-lever and turn system performance around. Trian and related parties own a 16.3% stake in Wendy's, according to a regulatory filing cited by Reuters. Trian declined to comment on the rejection, Reuters reported.

Trian has a long history with the company. It considered taking Wendy's private in 2022 and backed away in 2023, according to Reuters.

How the rights plan works

The board adopted the plan on November 4, effective immediately. Rights become exercisable if a person or group acquires 15% or more of Wendy's outstanding common stock, or if a holder of 15% or more acquires additional shares, in either case without approval from the board or the independent committee. Shareholders receive one right for each share held as of the close of business on November 16, and the plan expires on November 3, 2027.

Wendy's said the plan applies equally to all current and future shareholders and is not intended to keep the board from considering fair offers. In adopting it, the board also considered that the investor group had rejected the company's offer of a customary standstill agreement.

The standalone plan operators heard

Rejecting the bid puts the focus on Dave's Way, which Wendy's describes in five pillars: a menu with quality food at real value, distinct branding and marketing to drive demand, operational excellence, a winning digital experience to build frequency, and restaurants as the engine for growth. The company has also established a Strategic Activation Office to support execution.

The committee tied its confidence to President and CEO Bob Wright, named to the role in May, and to the plan he and his executive team recently presented to franchisees at the 2026 Wendy's convention. For a system of more than 7,000 restaurants worldwide, that plan now sets the agenda for franchisees, suppliers and marketing partners.

The plan comes as the business works through a sales decline. In the third quarter, Wendy's reported revenue of $547 million, down 0.5% year over year, with global systemwide sales down 5.9% and U.S. same-restaurant sales down 5.7%, according to Inside Retail.

Morgan Stanley and Goldman Sachs are serving as financial advisers to the independent committee, with Simpson Thacher & Bartlett as its legal counsel. Kirkland & Ellis is legal adviser to the company.